Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,120.00
Bid: 9,122.00
Ask: 9,126.00
Change: 16.00 (0.18%)
Spread: 4.00 (0.044%)
Open: 9,156.00
High: 9,156.00
Low: 8,972.00
Prev. Close: 9,104.00
NXT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of FatFace

13 Oct 2023 15:11

RNS Number : 1213Q
Next PLC
13 October 2023
 

 

Date:

13th October, 2023

 

Contacts:

Alistair Mackinnon-Musson

Rowbell PR - NEXT PLC

next@rowbellpr.com

Tel: 020 7717 5239

 

 

Lucy Legh / Joanna Clark

HeadLand PR - FatFace

fatface@headlandconsultancy.com

Tel: 020 3805 4822

 

 

Photographs:

FatFace images: https://wetransfer.com/downloads/8129c123c5487cee07c21aaf33ae9d8920231009130336/013359

 

NEXT images:  http://www.nextplc.co.uk/media/image-gallery/campaign-images

NEXT PLC

Acquisition of FatFace

NEXT plc ("NEXT") announces that it has signed terms to acquire FatFace for a total equity value of £115.2m ("Consideration") from a consortium of Financial Institutions (the "Sellers"). 

The Consideration will be settled partly in cash and partly by the issue of new NEXT shares and management equity rolling over into the new structure. The transaction will not materially impact the NEXT Group's underlying profit before tax or EPS in the current year.

Upon completion of this transaction, which is expected to take place within the next few weeks, NEXT will hold 97% of the equity and FatFace's management will hold 3% in the business. Management will also participate in an additional performance related equity scheme. FatFace will retain its management autonomy and creative independence. The company will retain its own Board of Directors and continue to be based in Havant, Hampshire, UK. FatFace has been a LABEL brand selling on next.co.uk since 2016 and it is anticipated that it will migrate its online operations onto NEXT's Total Platform within the next twelve months.

Today's announcement follows a period of strong trading for FatFace under the leadership of its CEO Will Crumbie. In the 52 weeks to 27 May 2023, FatFace achieved total sales of £282m. Statutory profit before tax in the same period was £19.5m. Digital channels account for 40% of FatFace sales, with the remainder largely coming from their retail stores. It is anticipated that the company will continue to trade and develop its own retail store portfolio.

Will Crumbie, who joined FatFace as CFO in 2014 and became CEO in 2021, will continue to lead the business.

-Ends-

About NEXT

NEXT plc (LON: NXT) is a FTSE 100 company based in Leicester and is one of the UK's leading online clothing retailers. NEXT has around 460 stores in the UK and Ireland and an online presence in over 70 countries selling the NEXT brand and over 700 other fashion, home and beauty brands, including FatFace.

About FatFace

FatFace is a British, family, lifestyle clothing brand that is Made for Life. With a unique heritage, FatFace creates product ranges across womens, mens, kids, footwear and accessories for the whole family to live life in. FatFace products are designed with purpose and built to last. Considered Style. Trusted Quality. Responsibly sourced.

FatFace is a multichannel retailer with a thriving UK and international digital business as well as over 180 stores in the UK and Ireland, over 25 stores in the US and Canada and a highly engaged social community. FatFace has 1.8m active customers. FatFace is a brand with sustainability at its core, with a clear strategy around three key pillars - product, planet, and community. The brand was recently awarded B Corp? status, a testament to its achievements against these pillars.  www.fatface.com

FatFace and the Sellers were advised by Rothschild & Co as financial adviser and Addleshaw Goddard as legal adviser. NEXT was advised by EY and Eversheds Sutherland.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQMJBITMTMBBPJ
Date   Source Headline
26th Apr 20246:12 pmRNSDirector/PDMR Shareholding
23rd Apr 20244:31 pmRNSHolding(s) in Company
12th Apr 20242:16 pmRNSAnnual Financial Report
8th Apr 20244:43 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
26th Mar 20249:50 amRNSHolding(s) in Company
22nd Mar 20242:26 pmRNSDirector/PDMR Shareholding
22nd Mar 20242:24 pmRNSDirector/PDMR Shareholding
22nd Mar 20249:15 amRNSDirector Declaration
21st Mar 20241:15 pmRNSDirector Declaration
21st Mar 202412:50 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNEXT plc Results for the Year Ended January 2024
1st Mar 20249:00 amRNSTotal Voting Rights
19th Feb 20242:27 pmRNSClosed Period Share Repurchase Programme
15th Feb 20244:58 pmRNSTransaction in Own Shares
6th Feb 20245:12 pmRNSTransaction in Own Shares
2nd Feb 20245:10 pmRNSTransaction in Own Shares
1st Feb 20245:20 pmRNSTransaction in Own Shares
1st Feb 20248:00 amRNSTotal Voting Rights
23rd Jan 20245:17 pmRNSTransaction in Own Shares
23rd Jan 20242:44 pmRNSDirector Appointment
22nd Jan 20245:41 pmRNSTransaction in Own Shares
17th Jan 20243:48 pmRNSDirector/PDMR Shareholding - Replacement
17th Jan 202412:00 pmRNSDirector Appointment
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
5th Jan 202412:00 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTrading Statement
2nd Jan 20248:00 amRNSTotal Voting Rights
19th Dec 20234:45 pmRNSHolding(s) in Company
4th Dec 202310:45 amRNSDirector/PDMR Shareholding
4th Dec 202310:34 amRNSDirector/PDMR Shareholding
1st Dec 20238:00 amRNSTotal Voting Rights
14th Nov 20234:57 pmRNSHolding(s) in Company
13th Nov 202312:30 pmRNSAGM Update
1st Nov 20238:00 amRNSTotal Voting Rights
1st Nov 20237:00 amRNSTrading Statement
19th Oct 20234:00 pmRNSDirector/PDMR Shareholding
18th Oct 20233:00 pmRNSNew Issue and Additional Listing
13th Oct 20233:11 pmRNSAcquisition of FatFace
3rd Oct 20233:19 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:00 pmRNSBoard Changes
2nd Oct 20238:30 amRNSTotal Voting Rights
25th Sep 20235:15 pmRNSDirector/PDMR Shareholding
25th Sep 20235:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20234:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSResults for the Half Year Ending July 2023
1st Sep 202312:00 pmRNSTotal Voting Rights
1st Sep 20239:30 amRNSAcquisition of Warburg Pincus’ Interest in Reiss
4th Aug 20234:07 pmRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.